contact@eolo-pharma.com
EOLO PHARMA announced that it has received approval to initiate a Phase 1 clinical
EOLO PHARMA today announced that it has dosed the first subjects in Phase 1
In this blog post, we will explore the importance of collaboration in the drug
In this blog post, an interview with one of Eolo Pharma’s co-founders, Carlos Batthyany,
explores how Eolo Pharma is using innovative approaches and advanced technologies to revolutionize the
Non-communicable diseases (NCDs) like cardiovascular disease, neurodegenerative disorders, and autoimmune conditions are on the
Te damos la bienvenida a WordPress. Esta es tu primera entrada. Edítala o bórrala,
